These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7543349)

  • 1. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
    Brohée D; Cauchie P; Nève P
    Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
    [No Abstract]   [Full Text] [Related]  

  • 2. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
    Adami F; Semenzato G; Menestrina F; Chilosi M
    Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
    Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
    Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of chronic lymphocytic leukaemia with myeloid associated antigen.
    Kawamata N; Maruyama Y; Toda S; Takase K; Akiyama H; Sakamaki H; Onozawa Y
    Br J Haematol; 1992 Jan; 80(1):129-30. PubMed ID: 1346967
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
    Paglieroni T; Caggiano V; MacKenzie MR
    Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders.
    Daenen S; van Voorst Vader PC; Blom N; Pietens J; Hollema H; Smit JW
    Br J Haematol; 1993 Oct; 85(2):307-12. PubMed ID: 7506566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of CDS+ of B-lymphocytes in the physiopathology of the hematopoietic system].
    Pluta A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):148-50. PubMed ID: 1279643
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate lymphocytic lymphoma massively involving the gastrointestinal tract.
    Tsutsumi Y; Osamura RY; Makuuchi H
    Pathol Int; 1996 May; 46(5):380-3. PubMed ID: 8809886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5- B cells in patients with chronic lymphocytic leukaemia (CLL).
    Nouri AM; Smith S; Oliver TR; Newland AC; Macey MG
    Eur J Cancer; 1998 Sep; 34(10):1618-22. PubMed ID: 9893639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of myeloid associated antigens in chronic lymphocytic leukaemia.
    Pinto A; Zagonel V; Carbone A; Del Vecchio L
    Br J Haematol; 1992 Sep; 82(1):173-5. PubMed ID: 1358172
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
    Scrivener S; Kaminski ER; Demaine A; Prentice AG
    Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal CD5 + B-lymphocytosis resembling chronic lymphocytic leukaemia.
    Lush CJ; Vora AJ; Campbell AC; Wood JK
    Br J Haematol; 1991 Sep; 79(1):119-20. PubMed ID: 1716959
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia.
    Espinosa A; Bjørk P; Magnussen K; Moen T; Sørum Y
    Leuk Lymphoma; 2003 Jan; 44(1):193-6. PubMed ID: 12691163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen density in B-cell chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Poncelet P
    Am J Clin Pathol; 1995 Mar; 103(3):375. PubMed ID: 7872264
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
    Lavabre-Bertrand T; Janossy G; Exbrayat C; Bourquard P; Duperray C; Navarro M
    Leukemia; 1994 Sep; 8(9):1557-63. PubMed ID: 7522294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.